Clinical and microbiological response of mice to intranasal inoculation with Lactococcus lactis expressing Group A Streptococcus antigens, to be used as an anti-streptococcal vaccine-Reference-Cited by-同舟云学术

Clinical and microbiological response of mice to intranasal inoculation with Lactococcus lactis expressing Group A Streptococcus antigens, to be used as an anti-streptococcal vaccine

Published:2018-11 Issue:11 Volume:62 Page:711-719
ISSN:0385-5600
Container-title:Microbiology and Immunology
language:en
Short-container-title:Microbiol Immunol

Author:

García Patricia C.¹,Paillavil Braulio A.¹,Scioscia Natalia¹,Dale James B.²,Legarraga Paulette¹,Salazar-Echegarai Francisco J.³,Bueno Susan M.³,Kalergis Alexis M.³⁴,Wozniak Aniela¹⁴

Affiliation:

1. Laboratory of Microbiology; Department of Clinical Laboratories; School of Medicine; Pontifical Catholic University of Chile; Santiago 8331010 Chile

2. Department of Medicine; University of Tennessee Health Science Center and the Department of Veterans Affairs Medical Center; Memphis, TN 38163 USA

3. Department of Molecular Genetics and Microbiology; School of Biological Sciences; Millennium Institute on Immunology and Immunotherapy; Pontifical Catholic University of Chile; Santiago 8331010 Chile

4. Department of Endocrinology; School of Medicine; Pontifical Catholic University of Chile; Santiago 8331010 Chile

Funder

FONDEF-CONICYT (National Fund for Scientific and Technological Development; Chilean Government)

Publisher

Wiley

Subject

Virology,Immunology,Microbiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1348-0421.12657/fullpdf

Reference21 articles.

1. A novel live vector Group A Sstreptococcal emm Type 9 vaccine delivered intranasally protects mice against challenge infection with emm Type 9 Group A Streptococci;Wozniak;Clin Vacc Immunol,2014

2. Protective immunity induced by an intranasal multivalent vaccine comprising 10 Lactococcus lactis strains expressing highly prevalent M-protein antigens derived from Group A Streptococcus;Wozniak;Microbiol Immunol,2018

3. Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines;Bermúdez-Humarán;Microb Cell Fact,2011

4. A review on Lactococcus lactis: From food to factory;Song;Microb Cell Fact,2017

5. Lactococcus lactis: A new strategy for vaccination;Azizpour;Avicenna J Med Biotechnol,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral Live-Carrier Vaccine of Recombinant Lactococcus lactis Inducing Prophylactic Protective Immunity Against Helicobacter pylori Infection;Probiotics and Antimicrobial Proteins;2024-09-10

2. Mucosal Immunization Has Benefits over Traditional Subcutaneous Immunization with Group A Streptococcus Antigens in a Pilot Study in a Mouse Model;Vaccines;2023-11-17

3. Development of fluorescence-labeled antibody for immune checkpoint inhibitor using engineered probiotics;AMB Express;2023-01-12

4. Development of an implantable three-dimensional model of a functional pathogenic multispecies biofilm to study infected wounds;Scientific Reports;2022-12-17

5. Update on group A streptococcal vaccine development;Current Opinion in Infectious Diseases;2020-06